Ariston Pharma Nova Tech Private Limited
About Ariston Pharma Nova Tech Private Limited
Data last updated:
Ariston Pharma Nova Tech Private Limited is a private limited company based in Hyderabad, Telangana, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 October 2012.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PTC083734. The company has 4 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹66.99 Lakh. It is led by directors including Vedprakash Vyas and Rajesh Chillale (Irp/Rp/Liquidator).
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at D No.5 – 5 – 35/136/B Ground Floor Prasanthi Nagar Ida Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2019, the company reported a revenue of ₹20.3 Cr, a decline of 47% compared to the previous year. For the same year it recorded a net profit of ₹12.04 Lakh (net margin 0.6%) and EBITDA of ₹1.11 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6.09 Cr on record. Court records list 10 cases involving the company, including 5 filed by the company and 5 filed against it; 2 cases are pending. The company has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹2.82 Cr; the latest was in March 2019. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Neomediispecs Private Limited with revenue of ₹20.5 Cr.
Company details
CIN history
Ariston Pharma Nova Tech has one previous CIN (Corporate Identification Number): U24232AP2012PTC083734. The current CIN is U24232TG2012PTC083734, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PTC083734 | Current |
| U24232AP2012PTC083734 | Previous |
Contact details
Ariston Pharma Nova Tech Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressD No.5 – 5 – 35/136/B Ground Floor Prasanthi Nagar Ida Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ariston Pharma Nova Tech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ariston Pharma Nova Tech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ariston Pharma Nova Tech Private Limited, buy the company report.
Financials of Ariston Pharma Nova Tech Private Limited
FY 2019 filings availableAriston Pharma Nova Tech Private Limited reported revenue of ₹20.3 Cr (down 47% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 47% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹20.3 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ariston Pharma Nova Tech Private Limited, buy the company report.
Board of directors of Ariston Pharma Nova Tech Private Limited
Ariston Pharma Nova Tech has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vedprakash Vyas | Director | 19 Oct 2012 | 14 Years 0 Months | As last reported |
| Rajesh Chillale Also directs: Irr Insolvency Professionals Private Limited | Irp/Rp/Liquidator | 24 May 2024 | 2 Years 5 Months | As last reported |
| Subhash Goverdhandasji Bissa Also directs: Avant Garde Medchem Private Limited | Director | 25 Sep 2019 | 7 Years 1 Months | As last reported |
| Shankar Sharma Also directs: Ishwara Feed & Feed Supplements LLP | Director | 16 Oct 2024 | 2 Years 0 Months | As last reported |
| Rounak Sharma | Director | 16 Oct 2024 | 2 Years 0 Months | As last reported |
Peer comparison
Ariston Pharma Nova Tech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neomediispecs Private Limited | ₹20.5 Cr (FY 2025) | -24.0% | Chennai, Tamil Nadu, India | |||
| Apollo Ingredients India Private Limited | ₹20.45 Cr (FY 2024) | -30.0% | Thane, Maharashtra, India | |||
| Noronic Pharmaceutical Private Limited | ₹20.39 Cr (FY 2023) | 130.0% | Kadi, Gujarat, India | |||
| Ukay Remedys Private Limited | ₹20.31 Cr (FY 2024) | 29.0% | Vasai, Maharashtra, India | |||
| Ariston Pharma Nova Tech Private Limitedthis company | ₹20.3 Cr (FY 2019) | ₹12.04 Lakh | 0.6% | -47.0% | 24 | Hyderabad, Telangana, India |
| Janya Biocare Private Limited | ₹20.29 Cr (FY 2025) | -19.0% | Roorkee, Uttarakhand, India | |||
| Scikem Pharmaceuticals Private Limited | ₹20.26 Cr (FY 2024) | -43.0% | Hydertabad, Telangana, India |
To see the full peer comparison of Ariston Pharma Nova Tech Private Limited, buy the company report.
Shareholding
The shareholding of Ariston Pharma Nova Tech Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ariston Pharma Nova Tech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2017 | 100093057 | Syndicate Bank | ₹9.4 Lakh | Open | |
| 09 Nov 2015 | 10603323 | Syndicate Bank | ₹6 Cr | Open |
To see the full charge records of Ariston Pharma Nova Tech Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Ariston Pharma Nova Tech Private Limited has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹2.82 Cr; the latest was in March 2019.
Deals on record (4 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2015 | Funding round | ₹84 Lakh | Investors: 2 individuals |
| Mar 2014 | Funding round | ₹16 Lakh | Investors: 3 individuals |
| Mar 2013 | Funding round | ₹15 Lakh | Investors: 2 individuals |
To see the full deal history of Ariston Pharma Nova Tech Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ariston Pharma Nova Tech Private Limited has 10 court cases on record: 5 filed by Ariston Pharma Nova Tech, 5 filed against it. 2 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 2 |
| High courts | 5 | 0 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solapur, Maharashtra | Civil suit | Filed against the company by Smruthi Organics Ltd Throgh Vijay Changale | Pending |
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed against the company by M/S Vasudha Pharma Chem Ltd Rep by Rajendra Prasad | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by M/S Vasudha Pharma Chem Ltd Rep by Rajendra Prasad | Disposed |
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed against the company by State of Telangana | Pending |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by Aditya Birla Fin. Ltd. | Disposed |
To see the full case history of Ariston Pharma Nova Tech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ariston Pharma Nova Tech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ariston Pharma Nova Tech Private Limited has a workforce of 24 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Ariston Pharma Nova Tech has 4 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ariston Pharma Nova Tech Private Limited, buy the company report.
Recent activity
Ariston Pharma Nova Tech Private Limited has 10 board changes on record since 2012: 5 appointments and 5 cessations. The latest: Rounak Sharma was appointed as Director on 16 Oct 2024.
4 earlier events are in the company report.
Frequently asked questions
Ariston Pharma Nova Tech is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Ariston Pharma Nova Tech is a company under liquidation, formerly operating as a private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 October 2012 and is registered under CIN U24232TG2012PTC083734. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Ariston Pharma Nova Tech has 5 current directors:
- Vedprakash Vyas - Director
- Subhash Goverdhandasji Bissa - Director
- Shankar Sharma - Director
- Rounak Sharma - Director
- Rajesh Chillale - Irp/Rp/Liquidator
The latest financial statements of Ariston Pharma Nova Tech on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Ariston Pharma Nova Tech is U24232TG2012PTC083734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ariston Pharma Nova Tech has open charges of ₹6.09 Cr and no satisfied charges on record as per latest MCA filings.
Ariston Pharma Nova Tech has 10 court cases on record: 5 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.
Ariston Pharma Nova Tech was incorporated on 19 October 2012. It is registered with the Registrar of Companies, Hyderabad.
Ariston Pharma Nova Tech has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹2.82 Cr; the latest was in March 2019.
The peers of Ariston Pharma Nova Tech by revenue are Neomediispecs Private Limited, Apollo Ingredients India Private Limited, Noronic Pharmaceutical Private Limited, Ukay Remedys Private Limited, Janya Biocare Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rounak Sharma was appointed as Director on 16 Oct 2024. Shankar Sharma was appointed as Director on 16 Oct 2024. Rajesh Chillale was appointed as Irp/Rp/Liquidator on 24 May 2024. Ariston Pharma Nova Tech has 10 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
